Add-on spironolactone as antagonist of the NRG1-ERBB4 signaling pathway for the treatment of schizophrenia: Study design and methodology of a multicenter randomized, placebo-controlled trial
螺内酯作为NRG1-ERBB4信号通路拮抗剂用于治疗精神分裂症：一项多中心随机安慰剂对照试验的研究设计和方法
期刊:Contemporary Clinical Trials Communications
影响因子:1.4
doi:10.1016/j.conctc.2020.100537
Hasan, Alkomiet; Roeh, Astrid; Leucht, Stefan; Langguth, Berthold; Hansbauer, Maximilian; Oviedo-Salcedo, Tatiana; Kirchner, Sophie K; Papazova, Irina; Löhrs, Lisa; Wagner, Elias; Maurus, Isabel; Strube, Wolfgang; Rossner, Moritz J; Wehr, Michael C; Bauer, Ingrid; Heres, Stephan; Leucht, Claudia; Kreuzer, Peter M; Zimmermann, Stephanie; Schneider-Axmann, Thomas; Görlitz, Thomas; Karch, Susanne; Egert-Schwender, Silvia; Schossow, Beate; Rothe, Philipp; Falkai, Peter
